Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

865140

registered interest
date	16/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Huddersfield Royal Infirmary
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 March to Question 131949 on Huddersfield Royal Infirmary, on what date the Independent Reconfiguration Panel's report on the potential downgrading of Huddersfield Royal Infirmary will be made public.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	133007
answer	answer is ministerial correction date of answer 21/03/2018 answer text <p>The Joint Chairs of the Calderdale and Kirklees Joint Health Scrutiny wrote to the Department last year formally referring the National Health Service proposal, Right Care Right Time Right Place – Proposed future arrangements for hospital and community health services in Calderdale and Greater Huddersfield. We referred the case to the Independent Reconfiguration Panel in January. An announcement will be made in due course.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 21/03/2018 16:35:07 answering member 4095 label Biography information for Steve Barclay
tabling member	4649 label Biography information for Thelma Walker

862303

registered interest
date	14/03/2018
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Motor Vehicles: Exhaust Emissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of Transport, for what reasons his Department's consultation entitled Road Vehicles Improving Air quality and Safety has run for a period of four weeks rather than the 12 weeks recommended in the Code of Practice on Consultation.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	132722
answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>The Government’s Consultation Principles replaced the previous Code of Practice in July 2012. The latest version dated 14 January 2016 requires that “Consultations should last for a proportionate amount of time”. In this case, the proposals were the subject of informal discussion between the UK motor industry and the department’s technical experts prior to the consultation launch.</p><p> </p><p> </p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 19/03/2018 15:00:27 answering member 3991 label Biography information for Jesse Norman
tabling member	4649 label Biography information for Thelma Walker

860592

registered interest
date	12/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Huddersfield Royal Infirmary
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the Independent Reconfiguration Panels report on the potential downgrading of Huddersfield Royal Infirmary to be made public.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	131949
answer	answer is ministerial correction date of answer 15/03/2018 answer text <p>Last year, the Calderdale and Kirklees Joint Health Scrutiny Committee referred to the Secretary of State the Calderdale Clinical Commissioning Group’s and Greater Huddersfield Clinical Commissioning Group’s proposals entitled “Right Care Right Time Right Place – Proposed future arrangements for hospital and community health services in Calderdale and Greater Huddersfield” under the Local Authority (Public Health, Health and Wellbeing Boards and Health Scrutiny) Regulations 2013. The Secretary of State has asked the Independent Referral Panel for their advice on this matter, and an announcement will be made in due course.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 15/03/2018 14:12:24 answering member 4095 label Biography information for Steve Barclay
tabling member	4649 label Biography information for Thelma Walker

856077

registered interest
date	06/03/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Dogs: Theft
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what steps her Department has taken to reduce dog theft in the last 12 months.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	131243
answer	answer is ministerial correction date of answer 12/03/2018 answer text <p>The Government understands the distress that can be caused by the theft of a pet. It is therefore important that these crimes, when they take place, are reported to the police so that they can be investigated and, where appropriate, the perpetrators taken through the courts and given appropriate sentences.</p><p>In 2017-18 the Government is providing police forces in England and Wales with direct Government funding worth over £7.5 billion to tackle all types of crime. As far as the police response to individual incidents are concerned, it is for Chief Constables and Police and Crime Commissioners, as operational leaders and elected local representatives, to decide how best to deploy resources to manage and respond to crime and local priorities.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins question first answered 12/03/2018 17:47:44 answering member 4399 label Biography information for Victoria Atkins
tabling member	4649 label Biography information for Thelma Walker

855579

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department has allocated to medical research for the development of new medicines in each of the last three years.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130886
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The Department funds research via the National Institute for Health Research (NIHR).</p><p> </p><p>The types of biomedical and health related research that are funded by NIHR and other funders can be classified using the Health Research Classification System (HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical treatments and therapeutic interventions and can be used to classify NIHR Programme Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which supports clinical trials into pharmaceutical treatments and therapeutic interventions. CRN funding data can be calculated based on the number of recruiting 'Clinical Trial of an Investigational Medicinal Product (CTIMP)' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three years where complete data is available is shown in the following table:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p> </p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research which may also contribute to the development and evaluation of pharmaceutical treatments and therapeutic interventions carried out across NIHR Infrastructure is not coded by the HRCS scheme so cannot be wholly attributed to individual research topics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 16:43:10 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855580

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the level of funding from the public purse to be allocated to research for medicines in each of the next three years.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130887
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The Department funds research via the National Institute for Health Research (NIHR).</p><p> </p><p>The NIHR welcomes funding applications for research into a wide range of areas but does not usually ring-fence funds for particular topics. Awards are made in open competition on the basis of importance of topics to patients and heath and care services, value for money, and scientific quality judged through peer review. The amount of future NIHR funding in specific topic areas will depend on the quality and quantity of research proposals submitted to NIHR for review. As such, NIHR does not hold projected funding allocations specifically for research into medicines.</p><p> </p><p>Information on individual projects funded by the NIHR can be found at:</p><p> </p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p> </p><p>However, NIHR does hold information on previous spend on the types of biomedical and health related research that are funded by NIHR and other funders, classified using the Health Research Classification System (HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical treatments and therapeutic interventions and can be used to classify NIHR Programme Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which supports clinical trials into pharmaceutical treatments and therapeutic interventions. CRN funding data can be calculated based on the number of recruiting ' Clinical Trial of an Investigational Medicinal Product (CTIMP) ' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three years where complete data is available is set out below:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p> </p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research which may also contribute to the development and evaluation of pharmaceutical treatments and therapeutic interventions carried out across NIHR Infrastructure is not coded by the HRCS scheme so cannot be wholly attributed to individual research topics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 16:36:35 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855581

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that (a) funding from the public purse for medical research is transparent; and (b) that medicines produced a result of funding from the public purse are affordable.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130888
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The National Institute for Health Research (NIHR) is funded through the Department to improve the health and wealth of the nation through research. Full and open access to the knowledge generated by research is of the utmost importance to the NIHR. The NIHR commitment to transparency, the NIHR Journals Library, open access policy, and endorsement of the World Health Organization joint statement on the disclosure of results ensures that ideas and knowledge derived from publicly funded research are made available and accessible for public use.</p><p> </p><p>The National Institute for Health and Care Excellence technology appraisal guidance and the associated funding requirement plays an important role in ensuring that patients have access to cost-effective new medicines, including medicines developed from public research.</p><p> </p><p>The recent Government and partner bodies response to the Accelerated Access Review sets out how we will work with industry and the health system to create a streamlined and sophisticated approvals system so that cost-effective breakthrough products – be they drugs, devices, digital or diagnostics – can get into the National Health Service as fast as possible.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 13:57:44 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855682

registered interest
date	05/03/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, when his Department plans to respond to the correspondence dated 19 December 2017 from the hon. Member for Colne Valley on a constituent’s concerns over EU nationals.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130988
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The response to the hon. Member’s correspondence dated 19 December 2017 regarding a constituent’s concerns about EU nationals was dispatched by the Department for Exiting the European Union on 22 February 2018.</p> answering member constituency Wycombe answering member printed Mr Steve Baker question first answered 13/03/2018 16:16:49 answering member 4064 label Biography information for Mr Steve Baker
tabling member	4649 label Biography information for Thelma Walker

855683

registered interest
date	05/03/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, when his Department plans to respond to the correspondence dated 11 January 2018 from the hon. Member for Colne Valley on a constituent’s concerns about leaving the EU.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130989
answer	answer is ministerial correction date of answer 15/03/2018 answer text <p>The Department for Exiting the European Union responded to the hon. Member for Colne Valley’s correspondence regarding her constituent’s concerns about leaving the EU on Monday 12 March 2018.</p> answering member constituency Worcester answering member printed Mr Robin Walker question first answered 15/03/2018 13:57:57 answering member 4091 label Biography information for Mr Robin Walker
tabling member	4649 label Biography information for Thelma Walker

853329

registered interest
date	02/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nabiximols
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on reducing the cost of the drug Sativex in order to allow that drug to be prescribed to people suffering from MS.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130778
answer	answer is ministerial correction date of answer 12/03/2018 answer text <p>Sativex is licensed for the treatment of moderate to severe spasticity in multiple sclerosis (MS). It is normally prescribed on the National Health Service by a specialist doctor with experience of treating MS spasticity – consultant neurologists, consultant rehabilitation specialists and consultant pain specialists.</p><p> </p><p>When the National Institute for Health and Care Excellence (NICE) published its guideline on the treatment of adults with MS in 2014, it recommended that Sativex should not be offered as an option to treat spasticity in people with MS because it is not a cost effective treatment. NICE is responsible for determining whether its guidance should be updated following the publication of any significant new evidence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2018 17:05:09 answering member 4067 label Biography information for Steve Brine
tabling member	4649 label Biography information for Thelma Walker